Mount Laurel, NJ, United States of America

Xiaozhao Wang

This inventor holds 51 USPTO granted patents and 58 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in KRAS Inhibitors. Top assignees: Incyte Corporation, University of Pennsylvania. Active years: 2015-2026.

USPTO Granted Patents = 51 (Patent Applications = 58)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 20)

EPO Patents = 7 (Patent Applications = 28)

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 330(Granted Patents)

Location History:

Drexel Hill, PA (US) (2015 - 2017)
Mt. Laurel, PA (US) (2017)
Wilmington, DE (US) (2016 - 2020)
Mt. Laurel, NJ (US) (2017 - 2024)
Moorestown, NJ (US) (2023 - 2024)

Company Filing History:

University of Pennsylvania

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

KRAS Inhibitors

Tricyclic Compounds

Tetracyclic Compounds

Naphthyridine Compounds

Pyrrolotriazine Compounds

Quinoline Compounds

A2A Receptor Inhibitors

CDK2 Inhibitors

LSD1 Inhibitors

Pyrazolopyridines

Heterobicyclic Compounds

Vinyl Imidazole Compounds

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735424 - Fused pyrazine derivatives as A2A / A2B inhibitors (2026-09-15),

2. 12692276 - Tricyclic triazolo compounds as DGK inhibitors (2026-07-28),

3. 12600723 - Tetracyclic compounds as DGK inhibitors (2026-04-14),

4. 12600722 - Tetracyclic compounds as DGK inhibitors (2026-04-14),

5. 12600717 - Tricyclic compounds as inhibitors of KRAS (2026-04-14),

6. 12441742 - Naphthyridine compounds as inhibitors of KRAS (2025-10-14),

7. 12441727 - Tricyclic compounds as inhibitors of KRAS (2025-10-14),

8. 12415809 - Pyrrolotriazine compounds as tam inhibitors (2025-09-16),

9. 12378243 - Quinoline compounds as inhibitors of KRAS (2025-08-05),

10. 12331063 - Hetero-bicyclic inhibitors of KRAS (2025-06-17),

11. 12077539 - Imidazole and triazole KRAS inhibitors (2024-09-03),

12. 12060433 - CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy (2024-08-13),

13. 12030884 - Pyrazoloquinoline KRAS inhibitors (2024-07-09),

14. 12030883 - Hetero-tricyclic compounds as inhibitors of KRAS (2024-07-09),

15. 11999752 - Vinyl imidazole compounds as inhibitors of KRAS (2024-06-04),

Title: The Innovative Journey of Xiaozhao Wang

Introduction: Xiaozhao Wang, a talented inventor hailing from Mt. Laurel, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Xiaozhao Wang's latest patents include groundbreaking inventions in the field of artificial intelligence and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Xiaozhao Wang has worked for leading tech companies, pioneering new solutions and pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Throughout his career, Xiaozhao Wang has collaborated with top researchers, engineers, and scientists from around the globe, fostering a culture of creativity and excellence in all his projects.

Conclusion: Xiaozhao Wang's passion for innovation and his relentless drive to create a better future through his inventions make him a true visionary in the world of technology.